Granite Point Capital Management’s Puma Biotechnology PBYI Stock Holding History

Granite Point Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,944	Closed	-$227K	–	101
2015 Q2	$227K	Sell	1,944 -1,056	-35%	-$191K	0.17%	90
2015 Q1	$708K	Sell	3,000 -500	-14%	-$107K	0.51%	62
2014 Q4	$662K	Sell	3,500 -500	-13%	-$111K	0.61%	56
2014 Q3	$954K	Hold	4,000	–	–	0.98%	45
2014 Q2	$264K	Sell	4,000 -2,200	-35%	-$156K	0.19%	80
2014 Q1	$646K	Sell	6,200 -3,800	-38%	-$447K	0.57%	68
2013 Q4	$1.03M	Buy	+10,000	New	+$587K	0.62%	61

Other funds holding PBYI

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return